Publication | Open Access
Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: Safety analyses from the randomized, placebo-controlled, phase III TALAPRO-2 study
10
Citations
14
References
2024
Year
NCT03395197.
| Year | Citations | |
|---|---|---|
Page 1
Page 1